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Abstract:  New technologies are both making life more efficient and 
productive, and more complex and precarious.  Medical technologies in 
particular are proving to be a double-edged sword, increasing options and 
expectations while exciting important ethical concerns.  Advances have now 
extended our life-preserving capability well beyond our healing or vitality-
restoring capability.  This reality often results in great infirmity at the end of 
life, and it means that knowledge and care around end-of-life decisions is 
essential.  This paper examines the consent model in this setting, exploring 
concepts of ‘capacity’ and ‘best interests’, and the function of Advance 
Directives, drawing on legislative and judicial authorities from across Canada.  
In the course of the analysis, it exposes the ethical values which nourish these 
concepts and practices, and concludes with some practical suggestions for 
medical law practitioners giving advice in this highly emotive setting. 
 
 
INTRODUCTION 
 
New technologies are, in many ways, making life more efficient and more productive.  
Ironically, these same technologies are making life more complex and precarious.  Medical 
technologies in particular – in vitro fertilization, transplantation, stem cell therapies, 
advanced life support techniques – are proving to be a double-edged sword, increasing 
treatment options and expectations while simultaneously exciting ethical concerns about how 
they affect our humanity and personhood.  Additionally, and importantly for this paper, we 
now face the ambiguous circumstance where advances in medical technology have extended 
our life-preserving capability (ie: our ability to maintain a functioning body), but have failed 
to increase, to the same extent, our healing capability (ie: our ability to restore functionality 
or cure the underlying debilitating condition). 
Patients, families, treating physicians, and lawyers are increasingly presented with 
complex issues and difficult decisions which tangle healthcare desires, legal rights and duties, 
and ethical values.  Physicians, troubled when competent patients refuse treatment deemed 
vital (a well-entrenched right1), are doubly challenged when confronted with incompetent 
patients represented by substitute decision-makers (“SDMs”) demanding treatment deemed 
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1  In Canada, see AC v. Manitoba (Director of Child & Family Services), [2009] SCC 30 (26 June 2009), 
Rodriguez v. British Columbia (A.G.), [1993] 3 S.C.R. 519, and others.  In the UK, see Re T (adult: refusal of 
treatment), [1992] 4 All E.R. 649 (C.A.). 
‘medically futile’.2  Inevitably, when the way is unclear and the parties disagree as to the 
‘right’ course of action, the law must intercede.  At the risk of insinuating lawyers into every 
aspect of life (and death), it seems obvious that we have an important role to play at the 
endgame of life. 
Although few people adequately discuss their end-of-life desires, and fewer still 
execute ‘Advance Directives’ (“ADs”), intractable disputes over withholding or withdrawing 
life support are relatively rare.3  However, given the increasing longevity and advancing age 
of populations, and the ongoing life-sustaining/cognition-restoring deficit, such disputes will 
become more prevalent, with the result that lawyers will more frequently be called upon to 
represent families or health authorities when treatment disputes arise.  Given that these 
disputes are a source of tremendous distress for all involved,4 as tragically demonstrated by 
the nine-year legal battle for control over Terri Schiavo’s future,5 lawyers have an obligation 
– to medical and judicial institutions, to clients and their families, and to themselves – to 
understand the legal and ethical issues implicated. 
Given the above, this paper explores the current legal state in Canada of three core 
aspects of managing end-of-life situations, having reference to the UK where appropriate.6  
First, it briefly considers the consent model that has developed in western medical practice, 
focusing on its capacity element, which is particularly significant in end-of-life settings.  
Second, it explores the position of ADs, which extend consent powers beyond the loss of 
capacity (and death).  Third, it explores the operation of ‘best interests’ assessments, an 
essential concept for shaping end-of-life decisions when the patient lacks capacity and has no 
applicable AD.  In the course of exposing and critiquing these concepts, it highlights the 
ethical values which nourish them.7 
The above analysis is structured around the following end-of-life-relevant statutes: the 
Alberta Personal Directives Act,8 the Manitoba Health Care Directives Act,9 and the Ontario 
Health Care Consent Act,10 and Substitute Decisions Act,11 which combine to govern this 
                                                 
2  Medical futility exists when a treatment is contra-indicated by a physician’s clinical judgment because 
it merely preserves a state of permanent unconsciousness or total dependence on intensive medical care with 
little or no chance of improving the patient’s underlying or overall condition: L. Schneiderman et al., “Medical 
Futility: Its Meaning and Ethical Implications” (1990) 112 Ann. Intern. Med. 949-954, M. Zucker & H. Zucker, 
Medical Futility: And the Evaluation of Life-Sustaining Interventions, (Cambridge: CUP, 1997), and K. Mason 
& G. Laurie, Mason & McCall-Smith’s Law and Medical Ethics, 7th ed. (Oxford: OUP, 2006), ch. 16. 
3  C. Weijer et al., “Bioethics for Clinicians: Dealing with Demands for Inappropriate Treatment” (1998) 
159 C.M.A.J. 817-821.   
4  See M. Solomon, “How Physicians Talk About Futility: Making Words Mean Too Many Things” 
(1993) 21 J. Clin. Ethics 231-237, and A. Simmonds, “Decision-Making by Default: Experiences of Physicians 
and Nurses with Dying Patients in Intensive Care” (1996) 12 Hum. Health Care Int. 168-172. 
5  This was a divisive family saga which exploded into a titanic public moral and political mêlée, and re-
opened the abortion and stem cell research debates in the US: see Re Guardianship of Schiavo (2001), 780 So. 
2D. 176 (Fla. App., 2nd Dist.).  For more, see G. Pradella, “Substituting a Judgment of Best Interests: Dignity 
and the Application of Objective Principles to PVS Cases in the UK” (2005) 12 Euro. J. Health Law 335-345. 
6  The UK is a useful touchstone because of its robust jurisprudence: the High Court, Family Division, 
which has inherent jurisdiction in England and Wales to make declarations with respect to patients lacking 
competence, disposes of, on average, 20 cases per year with respect to adults alone: see Re F (adult: court’s 
jurisdiction), [2000] 2 F.L.R. 512 (H.C. Fam.). 
7  ‘Values’ are the ideals that we, as individuals and as a society, hold, and which move us to respond 
(either positively or negatively) to possibilities and responsibilities.  For  more on values, see A. Bruce & J. Tait, 
“Interests, Values and Biotechnological Risk” (2003) InnoGen WP-7, at www.innogen.ed.ac.uk, and S. Harmon, 
“Regulation of Human Genomics and Genetic Biotechnology: Risks, Values and Analytical Criteria” (2005), 
InnoGen WP-40, at www.innogen.ac.uk/Publications/40-
Regulation_of_Human_Genomics_and_Genetic_Biotechnology. 
8  R.S.A. 2000, c. P-6. (PDA (Alta)) 
9  C.S.M. 1993, c. H-27. (HCDA (Man)) 
10  S.O. 1996, c. 2. (HCCA (Ont)) 
area.  These constitute a reasonable sample of Canadian jurisdictions and might together be 
considered representative of Canadian practices.12  Importantly, the paper also considers four 
recent end-of-life cases emanating from these jurisdictions: Scardoni v. Hawryluck;13 Re 
Grover;14 Jin (next friend of) v. Calgary Health Region;15 and Golubchuk v. Salvation Army 
Grace.16  The paper concludes by offering some practical suggestions for medical law 
practitioners giving advice in these highly emotive situations. 
 
CONSENT OF THE (AILING) PATIENT: CAPACITY TO CONSENT 
 
Medical law, like medicine itself, is concerned with human flourishing, but also with personal 
integrity.  Paternalism has gradually given way, hastened by medical research abuses in the 
last century, and a more patient-centred approach now prevails.  Medical law now uniformly 
imposes on clinicians the ‘consent model’, which demands that patients be empowered to 
make, or participate in, treatment decisions.  Under this model, individuals must consent 
before any treatment (any physical touching) can occur.  The consequences of unauthorised 
touching can be a finding of assault or battery (and civil or criminal liability).  In Starson v. 
Swayze,17 an important Canadian case, the Supreme Court of Canada articulated the principle 
as follows: 
 
[7] Ordinarily at law, the value of autonomy prevails over the value of 
effective medical treatment.  No matter how ill a person, no matter how likely 
deterioration or death, it is for that person ... to decide whether to accept a 
proposed medical treatment. 
 
Thus, consent must be sought, even for life-saving treatment, and patients can refuse to 
consent, even when the inevitable consequence is death.18  Conversely, as noted in R. (on the 
application of Burke) v. General Medical Council,19 where patients with capacity wish to be 
kept alive by ventilation or artificial-nutrition-hydration, there can be no question about the 
provision of same.  There can be no clinical indication to the contrary unless a decision has 
been taken that the life should come to an end, and that is not a decision that can lawfully be 
taken for competent patients who express the wish to remain alive. 
It is clear from the above that the consent model empowers the individual, exercising 
her own judgment, or no rational judgment whatsoever, to refuse medical treatment.  It also 
allows individuals to demand medical assistance, though they may not necessarily demand a 
specific treatment (which may not be clinically indicated or available).20  One can see, then, 
                                                                                                                                                        
11  S.O. 1992, c. 30. (SDA (Ont)) 
12  Most provinces have legislation governing ADs and the appointment of SDMs.  See British Columbia: 
Health Care (Consent) and Care Facility (Admission) Act, R.S.B.C. 1996, c. 48, and Adult Guardianship Act, 
R.S.B.C. 1996, c. 383; Newfoundland: Advanced Health Care Directives Act, S.N. 1995, c. A-4.1; Nova Scotia: 
Medical Consent Act, R.S.N.S. 1989, c. 279; Prince Edward Island: Consent to Treatment and Health Care 
Directives Act, S.P.E.I. 1996, c. 10; Quebec: Arts. 10-25 Quebec Civil Code; Saskatchewan: Health Care 
Directives and Substitute Health Care Decision Makers Act, S.S. 1997, c. H-0.001 
13  (2004), 69 O.R. (3d) 700 (S.C.). 
14  [2009] CanLII 16577 (Ont. S.C.). 
15  [2008] 2 W.W.R. 273 (Alt. Q.B.). 
16  [2008] 8 W.W.R. 299 (Man. Q.B.). 
17  [2003] 1 S.C.R. 722. 
18  See Manitoba (Director of Family & Child Services), supra, note 1. 
19  [2005] E.W.C.A. Civ. 1003 (C.A.). 
20  There is no unfettered right to choose treatments either under the Canadian Charter of Rights & 
Freedoms or the UK Human Rights Act 1998: see Auton (guardian ad litem of) v. British Columbia (A.G.) 
(2004), 245 D.L.R. (4th) 1 (S.C.C.), and R. v. Cambridge District Health Authority ex parte B (minor), [1995] 2 
that individual decision-making, with its myriad non-medical motivators, has risen to great 
prominence.  However, medical judgment is still important, and this is nowhere more readily 
demonstrated than in end-of-life settings. 
The Manitoba and Ontario Acts specifically endorse the consent model,21 whereas the 
Alberta Act assumes the model without reference.  As evidenced in this legislation, the 
cornerstone of the consent model is the individual’s capacity to consent, and all the statutes 
are in substantial agreement as to the conceptualisation and formulation of capacity (ie: 
people are entitled to make decisions when they are not labouring under mental or 
psychological conditions that negate their capability).  As one can imagine, end-of-life 
decisions, where infirmity can be quite pronounced, there is a particular need to ensure the 
capacity of patients (and to protect those lacking capacity).  The common law presumes 
capacity (in adults) and the Manitoba and Ontario Acts retain that position, proceeding on the 
assumption that capacity exists; those challenging capacity must prove its absence on the 
balance of probabilities.22  A person is deemed to have capacity when s/he is able to: (1) 
understand the information that is relevant to making a treatment decision; and (2) appreciate 
the reasonably foreseeable consequences of a decision or lack of decision.23 
The consent model, with its capacity prerequisite, protects self-determination and 
bodily integrity, and is therefore founded on two core ethical values, namely ‘human dignity’ 
and ‘autonomy’.  Dignity encompasses the idea that human beings, individually and 
collectively, are unique, deserving of honour and respect as amongst one another, and should 
be elevated above non-human species.24  It contributes to our shared sense of being, and our 
sense of inherent or ‘natural rights’ (ie: rights that are neither specifically granted nor 
legitimately violated by society), and it has informed the norms espoused by numerous 
international instruments.25  Autonomy is grounded in respect for the worth of human beings, 
and it encompasses physical, psychological, and legal liberty, and the right to be free from 
controlling influences (of others and of personal limitations) with respect to same.26  Indeed, 
                                                                                                                                                        
All E.R. 129 (C.A.). This is also the legal position in New Zealand: see Shortland v. Northland Health Ltd. 
(1999), 50 B.M.L.R. 255 (C.A.). 
21  See Preamble, HCDA (Man), and s. 1(c), HCCA (Ont).  The SDA (Ont) assumes the model without 
specifically addressing it. 
22  See Starson v. Swayze, supra, note 17, and see s. 3, HCDA (Man), which refers to the Manitoba Mental 
Health Act, and ss. 4(2) and (3), HCCA (Ont).  In the English context, see ss. 1(2), (3) and (4), and s. 2(4) of the 
Mental Capacity Act 2005, c. 30 (MCA (UK)). 
23  See s. 2, HCDA (Man), and s. 4(1), HCCA (Ont), and s. 45, SDA (Ont).  Section 1(b) of the Alberta 
Act adopts those two criteria as the definition of capacity, and s. 3 incorporates them into the definition of a 
person eligible to make an AD.  The English legislation adopts the same criteria, although it approaches the 
issue from the perspective of someone lacking capacity, stating that one lacks capacity and cannot make a 
decision where they lack the above capabilities: see ss. 2(1) and (2) and s. 3, MCA (UK).  These statutory tests 
are reflective of the common law as enunciated in Re C (adult: refusal of medical treatment), [1994] 1 All E.R. 
819 (H.C.), and Re MB (adult: medical treatment), [1997] 2 F.C.R. 541 (C.A.). 
24  For more on this value, see T. Beauchamp & J. Childress, Principles of Biomedical Ethics, 4th ed. 
(Oxford: OUP, 1994), D. Beyleveld & R. Brownsword, Human Dignity in Bioethics and Biolaw (Oxford: OUP, 
2001), and M. Cutter, “Genetic Databases and What the Rat Won’t Do: What is Dignity at Law?” (217-222) and 
D. Statman, “Human Dignity and Technology” (223-228) both in G. Arnason et al. (eds.), Blood and Data: 
Ethical, Legal and Social Aspects of Human Genetic Databases (Reykjavik: U. of Iceland Press, 2004). 
25  See United Nations Charter (1945), Universal Declaration of Human Rights (1948), American 
Declaration of the Rights & Duties of Man (1948), International Covenant on Economic, Social & Cultural 
Rights (1966), International Covenant on Civil & Political Rights (1966), African Charter on Human & Peoples’ 
Rights (1981), Declaration on the Rights of Persons Belonging to National or Ethnic, Religious & Linguistic 
Minorities (1992), Declaration on the Elimination of Violence Against Women (1993), Arab Charter on Human 
Rights (1994), UNESCO’s Universal Declaration of the Human Genome and Human Rights (1997). 
26  See T. Beauchamp & J. Childress, supra, note 24, at 121, S. Aksoy & A. Elmali, “The Core Concepts 
of the ‘Four Principles’ of Bioethics as Found in Islamic Tradition” (2002) 21 Med. Law 211-224, and R. 
the Ontario Act declares the enhancement of autonomy as one of its purposes, and the 
Supreme Court of Canada specifically considered it in Starson.27  One can thus say that 
dignity and autonomy have found a legal voice in the end-of-life decision-making 
framework.  The consent model, with its insistence on capacity and its mechanisms for 
testing same, might even be described as the ultimate expression of these ethical values. 
In the subject cases, capacity was not controversial – none of the patients had it.  In 
Scardoni, Holland, the 81 year-old patient with advanced Alzheimer’s, aspiration pneumonia, 
recurrent lung infections, painful bedsores and reflection contractures, was non-responsive 
and unable to recognise people.  In Grover, the previously partially disabled 81 year-old 
patient suffered a stroke which left her non-communicative and quadriplegic.  In Jin, the 
previously healthy 66 year-old patient fell and suffered a severe head injury causing 
unconsciousness, and was treated with brain inserts (to reduce pressure and ensure blood 
flow).  In Golubchuk, the patient also suffered a closed head injury.  He neither ambulated 
nor spoke, though there was some dispute over the level of his brain function, with his 
treatment team claiming non-responsiveness to stimuli.  All of the patients save Holland were 
on ventilators and required tube-feeding.  None were in a position to actively participate in 
decisions concerning their treatment.  As such, none of the cases addressed capacity in any 
detail, so they contain no pertinent discussion or development of the relevant values. 
 
ADVANCE DIRECTIVES AND THE (INCAPAX) PATIENT: FUTURE CONSENT 
 
In situations where the patient has lost capacity, it may be that they have left instructions 
(outlined the scope and limits of their future consent) in the form of an AD, executed when 
they were competent.  The Alberta and Manitoba Acts are expressly concerned with written 
ADs,28 whereas the Ontario Acts are broader, stating that a person, while capable, may 
express future treatment wishes either through (1) a Power of Attorney for Personal Care in 
prescribed form, (2) another written form, (3) oral statements, or (4) any other manner.29  
ADs can be amended or withdrawn,30 they only take effect once incapacity is proven,31 and, 
in such cases, one’s most recent capacity-supported wishes prevail.32  As a matter of common 
sense, an AD is not applicable if the patient retains capacity at the relevant time, or the 
condition/treatment is not captured by the terms of the AD. 
Under these Acts, the duly appointed SDM must pay close attention to the patient’s 
wishes, and conform to them (with respect to giving or refusing consent) whenever the 
circumstances are reasonably applicable.33  However, the Ontario Court of Appeal has 
cautioned that: 
 
… prior capable wishes are not to be applied mechanically or literally without 
                                                                                                                                                        
Gillon, “Ethics Needs Principles - Four Can Encompass the Rest - and Respect for Autonomy Should be ‘First 
Among Equals’” (2003) 29 J.M.E. 307-312. 
27  See s. 1(c), HCCA (Ont), which also lists facilitating treatment and promoting communication as 
purposes, and see paras. 7 and 11, Starson v. Swayze, supra, note 17. 
28  Both stipulate the ADs must be written, signed, dated, and witnessed: s. 5, PDA (Alta), s. 8, HCDA 
(Man).  See also ss. 24(3), (4) and (5) MCA, (UK).  The English Act states that a person, when he has capacity 
to do so, can specify that, in the event of loss of capacity, certain treatment is not to be carried out or continued, 
but where the treatment in question is life-sustaining, it must be in writing: see ss. 24 and 25, MCA (UK). 
29  See s. 5(2), HCCA (Ont), and s. 46, SDA (Ont), which erects the criteria for executing a Power of 
Attorney for Personal Care. 
30  See ss. 8 and 10, PDA (Alta), s. 9, HCDA (Man), and ss. 47 and 53, SDA (Ont). 
31  See s. 9, PDA (Alta), s. 6, HCDA (Man), and ss. 49 and 51, SDA (Ont). 
32  See s. 8, PDA (Alta), s. 9, HCDA (Man), and s. 5(3), HCCA (Ont). 
33  See s. 21(1)1, HCCA (Ont), and Neill v. Pellolio (2001), 151 O.A.C. 343, and ss. 11(7) and 26(1), 
MCA (UK). 
regard to relevant changes in circumstances. Even wishes expressed in 
categorical or absolute terms must be interpreted in light of the circumstances 
prevailing at the time the wish was expressed.34 
 
Similarly, the English Court of Appeal,35 considering patients who had lost capacity, held 
that directions in an AD are not necessarily determinative.  While the law requires 
compliance with valid ADs, this means nothing more than taking the wish into consideration 
when determining the patient’s best interests.  This approach recognises that treatment can 
prolong life indeterminately, but sometimes at the cost of terrible suffering.  It noted a very 
strong presumption in favour of taking steps which prolong life, holding that the best interests 
of the patient usually square with this presumption.  If doubt exists, life is typically preserved, 
in keeping with the sanctity of life value.  Moreover, every case on providing/continuing care 
will depend on its particular circumstances.  Where the patient is clearly dying, the goal may 
properly be to ease suffering (ie: ease the passing). 
The legislative schemes reflect this suspicion of mechanistic approaches.  For 
example, the Alberta Act states that an SDM (agent) must follow any clear instructions 
provided in the AD that are relevant to the decision to be made, and if the AD does not 
contain clear instructions, the SDM must (1) make the decision s/he believes the patient 
would have made in the circumstances, based on the SDM’s knowledge of the wishes, 
beliefs, and values of the patient.  If these are unknown, the SDM must make the decision 
s/he believes in the circumstances is in the patient’s ‘best interests’.36  The Manitoba Act 
states that an SDM (proxy) must comply with healthcare instructions where expressed; where 
they are not expressed the SDM must shall act in accordance with any wishes s/he knows the 
patient expressed when capable, and believes s/he would still act on if capable, even if that 
expression is contrary to instructions in the AD, but made after the execution of the AD.  If 
the SDM has no knowledge of the patient’s wishes, s/he must act in what s/he believes to be 
the patient’s ‘best interests’.37  The Ontario Act states that an SDM must give effect to the 
patient’s known wishes; if the patient’s wishes are unknown or are impossible to comply with 
in the particular circumstances, then the SDM must act in the patient’s ‘best interests’.38 
As with the consent model more generally, ADs constitute a preservation of 
autonomy, indeed an extension of autonomy, pushing it to periods where judgment can no 
longer be exercised by the patient (eg: ADs can even contain instructions on the use and 
disposition of the body).  While this approach is decidedly anti-communitarian (ie: an 
alternate approach might limit the patient’s post-morbid choices, vesting certain decisional 
powers with authorities responsible for public health and public health research), it is 
important for promoting another important value, namely ‘trust’.  In particular, trust in 
patients with physicians and health authorities; trust that they will make decisions based on 
the particular case and that advance that patient’s welfare.  This itself can have important 
public and personal health consequences, and so might be viewed as a reasonable concession 
to other public needs (eg: such as for tissue and organs). 
What about the cases?  The Ontario cases, Scardoni and Grover, are relevant here.  In 
                                                 
34  Conway v. Jacques (2002), 159 O.A.C. 236, at para. 31.  This caution is supported by M. Gordon & D. 
Levitt, “Acting on a Living Will: A Physician’s Dilemma” (1996) 155 C.M.A.J. 893-895, and by statements in 
the CMA Code of Ethics, supra, note 14, to the effect that a physician is never required to carry out instructions 
that conflict with his/her own ethical principles. 
35  R. (on the application of Burke), supra, note 19. 
36  See s. 14, PDA (Alta).  Section 15 outlines decisions the SDM is not entitled to make without express 
authority. 
37  See s. 13, HCDA (Man).  Section 14 outlines decisions the SDM is not entitled to make without 
express authority. 
38  See s. 21(1), HCCA (Ont), and s. 66, SDA (Ont). 
both cases, the patients had ADs and designated SDMs, and there was a dispute between the 
SDMs and physicians over the appropriate course to follow.  Under the Ontario Act, if the 
treating physician is of the opinion that, in arriving at his/her, the SDM failed to comply with 
his/her duties, the physician can apply to the Consent and Capacity Board (CCB) for a 
determination.39  As such, the physicians applied to the CCB seeking (1) determinations as to 
whether the SDMs, in taking the positions they did, were in compliance with their statutory 
duty to take decisions in the best interests of the patient, and (2) orders declaring that their 
own proposed course was lawful. 
In Scardoni, the physician considered ICU-administered ventilator and inotropic 
support, for respiratory failure and septic shock, to be medically futile because of the burden 
such treatment imposed and the impossibility of reversing the advanced stage of Holland’s 
Alzheimer’s.  Thus, she sought authorisation for the non-provision or withdrawal of such 
treatment should Holland experience another episode necessitating it in future.  The SDM 
argued that, since Holland was not in a vegetative state and not receiving ICU treatment, and 
could in future respond favourably to such treatment (as she had in past), authorising the 
physician as requested would amount to “a significant step down the slippery slope towards 
professionally-assisted euthanasia”. 
In reviewing the CCB’s decision permitting the physician to withdraw/withhold care, 
the court observed that the term “wellbeing” incorporates not only life itself, but quality of 
life considerations (eg: contentment, prosperity, happiness, health, pain levels and dignity), 
and that it has both a subjective and objective element.  Subjectively, the SDM must take into 
account the patient’s values, beliefs and wishes (some not necessarily directly applicable).  
Some of these may be inferred.  Objectively, the SDM must consider the benefits and 
burdens of treatment, which will be driven by medical evidence and interests.  On the 
subjective side, the Court noted that the CCB made its decision based on medical evidence 
from a physician who was neither aware of, nor had inquired after, the existence of an AD.  
Although coached in general terms, that AD was relevant to determining whether a patient’s 
wishes are applicable to the circumstances.  The Court was also critical of the CCB’s 
disregard for the patient’s religious beliefs (eg: a deeply-held Catholicism which valued the 
preservation and prolongation of life, and had prompted her to claim, “where there’s life, 
there’s hope”).  Though Holland had only made general statements of philosophy not directed 
at coping with the myriad conditions of advanced Alzheimer’s, they were relevant.  On the 
objective side, the Court complained that the CCB failed to elicit critical evidence about: (1) 
how long Holland would survive and in what degree of pain and/or discomfort should 
pneumonia recur; (2) whether Holland had any chance of recovery should pneumonia recur; 
and (3) what pain/discomfort might Holland suffer. 
The Court held that it is essential for the CCB to understand both the nature of the 
inquiry under each element of the ‘best interest’ test, and the medical evidence, and it could 
not infer, on a balance of probabilities, that the Board’s decision would have been the same 
had these errors not occurred.  It concluded: 
  
[99] It appears from the evidence ... that the appellants were emotionally 
                                                 
39  See s. 37(1), HCCA (Ont).  The CCB, established under the HCCA, is an independent tribunal which 
adjudicates consent and capacity issues under a variety of Acts with the intent of balancing the rights of the 
vulnerable and public safety: see http://www.ccboard.on.ca/scripts/english/aboutus/index.asp.  In hearings 
before the CCB, the treating physician, SDM, patient, and any other person specified by the CCB are eligible 
participants, and the CCB can give the SDM directions or substitute its own decision: see s. 37, HCCA (Ont).  
Under the English Act, a court is authorized to make declarations as to the lawfulness of the SDM’s conduct in 
relation to the patient: s. 15, MCA (UK).  In exercising its authority, the court can appoint a deputy to make 
further decisions on the patient’s behalf, and both the court and that deputy must take into consideration the 
patient’s best interests, as set out in the Act: ss. 16(3) and (6) and ss. 20(5) and (6), MCA (UK). 
upset and distressed at the meeting at which they declined to consent to the 
proposed plan of treatment and that their evidence at the hearing was far more 
specific with respect to their mother’s beliefs, values and wishes.  Mrs. 
Scardoni testified that they were intimidated.  At the conclusion of the hearing, 
Dr. Hawryluck indicated that her decision to apply to the Board was influenced 
by the appellants’ failure ... to be explicit about their mother’s views.  In view 
of the possibility that, having heard the appellants’ evidence at the hearing, as 
well as having knowledge of Mrs. Holland’s medical history since then, the 
physicians’ opinions of Mrs. Holland’s best interests may have changed, I do 
not intend to order a rehearing before the Board. 
  
In the result, the Court set aside the CCB’s decision without prejudice to any further 
application the physician might feel was warranted in light of Holland’s future condition. 
More recently, in Grover, the patient executed a standard form Health Care Directive 
naming her daughter as SDM.  It expressed the wish that, in the event of illness and 
incapacity, physicians do everything medically and surgically possible to cure her or prolong 
her life, including heroic measures.  After consulting the SDM on two treatment plans, one 
permitting the withdrawal of care, the other involving full treatment (the risks of which were 
high and the benefits questionable), the physician recommended the former, noting that 
Grover could not be kept indefinitely in the ICU.  The SDM demanded the second plan and 
could not be dissuaded (despite her siblings’ views that Grover would not wish to languish in 
her present condition).  The physician concluded that the SDM was not acting in Grover’s 
best interest, and applied to the CCB. 
The CCB had to consider whether the wish for heroic measures was applicable to the 
circumstances, and, if not, what were Grover’s best interests as between the two treatment 
plans.  Ultimately, it ordered the SDM to consent to the withdrawal of life support, and she 
appealed, claiming that its reasons were insufficient.  After concluding that the CCB’s 
reasons were sufficient, the Court articulated the dispute as follows: 
 
[20] ... The important issue, in dispute ... was whether the ... Level 4 care set out in 
the ... directive applied to Mrs. Grover’s circumstances ... .  A fair reading of the 
reasons ... makes it clear that the Board found the wish did not apply because when it 
was made Mrs. Grover did not take into account the nature and extent of the medical 
result to her from an event as devastating as her third stroke ... . 
 
On the issue of whether the CCB failed to take into account Grover’s wish for heroic 
measures, the SDM argued that the CCB should have sought evidence from nursing home 
staff to explore the details of Grover’s wish.  The Court held that the SDM, represented by 
counsel, could have called the physician, but, in any event, held he could have added little to 
the text in the AD.  Moreover, the CCB was aware of Grover’s wish for heroic measures.  
Thus, sufficient and relevant evidence existed and was weighed by the CCB.  On the issue of 
whether Grover’s wish was relevant to the circumstances, the Court noted that the SDM’s 
own evidence was equivocal enough that the CCB’s conclusion was justified.40  In dismissing 
the appeal and upholding the CCB’s order that treatment could be withheld, the Court noted 
                                                 
40  Parts of the transcript were reproduced, including the following exchange: Q: Have you had 
conversations with your mother specifically about how she would want to be dealt with in circumstances such as 
this where she had a ... brain stem stroke?  A: We didn’t talk about a third stroke, but as I say, she did adapt 
pretty well to any disability.  Q: You mentioned ... that your mother simply accepted ... the way she was; that 
was the prior stroke which was not nearly as devastating as the brain stem stroke, correct?  A: Yes.  Q: So the 
context in which she is mentioning these things to you ... are ... different ... .  A: That’s true. 
that this was a difficult case because the prior wish had been made so close in time to 
Grover’s third stroke. 
These cases illustrate the ambiguity around ADs.  First, they demonstrate the vital 
importance of intimate knowledge of the content of ADs, and of making healthcarers aware 
of them, and of considering them carefully when making decisions with respect to the patient.  
Conversely, they show that, even when ADs exist, they are neither absolute nor 
unconditional; they do not give patients an unfettered right to demand any and all treatment, 
but rather the ability to articulate a desire for a particular type of care (which may not be 
available in fact).  These cases also demonstrate the need for a robust approach to weighing 
the benefits and burdens of treatment.  Such an approach means making quality of life 
judgments, which are difficult, subjective and comparative.  Faced with ‘life (not) worth 
living’ evaluations, competition for scarce healthcare resources, and a constellation of other 
factors that will vary from case to case, some more compelling than others, decision-makers 
may find such undertakings troubling, even unsavoury.41  And this is why good relations 
amongst the relevant parties is so important; in Scardoni and Grover, that relationship had 
broken down. 
These cases are also noteworthy indicators that the jurisprudence is broadly reflective 
of critical ethical values.  The rulings are consistent with: 
 
• a careful interpretation and application of the value of preserving the inherent dignity 
of persons whose continued existence is at issue; 
 
• a frank recognition of the special position of human life, and each patient’s inherent 
and inviolable right to life, legitimately curtailed by conditions which form 
exceptional circumstances; 
 
• a full consideration of those elements which must reasonably and logically inform the 
exploration of an incompetent patient’s best interests and erstwhile autonomy; and 
 
• an implicit acceptance of both patients as individuals with unique value and place in 
the community, concomitant with a level of reverence and gravitas that the realisation 
of justice in such difficult circumstances requires. 
 
In short, these cases suggest that the courts are sensitive to the ethical values of dignity, 
autonomy, sanctity of life, and justice, if not always explicitly so, and to the inherent tensions 
between them (ie: values are not absolute and no single value can govern decisions).  Finally, 
they also demonstrate the vital importance of understanding the ‘best interests’ test, which is 
considered next. 
 
BEST INTERESTS OF THE (INCAPAX) PATIENT: WHO CONSENTS? 
 
The final key aspect to end-of-life decision-making is the concept of ‘best interests’.  If the 
AD does not expressly address the prevailing situation, or of it is impossible for the SDM to 
comply with the wishes as understood, then the SDM must act in what s/he believes to be the 
                                                 
41  J. Blackmer, “Tube Feeding in Stroke Patients: A Medical and Ethical Perspective” (2001) 28 Can. J. 
Neuro. Sci. 101-106.  P. Suber, “Against the Sanctity of Life” (1996) at www.earlham.edu/~peters/writing/ 
sanctity.htm [accessed 5 August 2005], at 8, suggests that perhaps we should not permit brain-dead patients to 
monopolise life-saving/preserving equipment at the risk of healthier patients becoming acute without them.  It 
should be noted, however, that where health authorities recommend withholding or withdrawing treatment, they 
are careful to point out that such distributive justice evaluations have played no role. 
patient’s ‘best interests’.  Similarly, in the absence of an AD, SDMs (whether family 
members, physicians, or public authorities) must make decisions based on the patient’s ‘best 
interests’.  But what does this term mean? 
First and foremost, it is about the paramountcy of patient welfare.  In Re J 
(minor)(wardship: medical treatment),42 a seminal case, Lord Donaldson MR stated that 
calculating best interests cannot be done with any mathematical precision: 
 
There is a very strong presumption in favour of a course of action which will 
prolong life, but … it is not irrebuttable. … [A]ccount has to be taken of the 
pain and suffering and quality of life which the [patient] will experience if life 
is prolonged. Account also has to be taken of the pain and suffering involved 
in the proposed treatment itself.43 
 
After affirming the instinct for survival, and reiterating the sanctity of life, he noted that the 
SDM must look at the situation from the point of view of the patient, and give effect to (or 
allow for) the fact that many people find an acceptable, if not reasonable, quality of life in 
situations which others might find intolerable.44  In Re L (medical treatment: benefit),45 
Dame Butler-Sloss added that the strong presumption in favour of preserving life is 
diminished where treatment is futile; the broadest subjective, objective, ethical and legal 
considerations notwithstanding, there is no obligation on the medical profession to provide 
medically futile treatment.46  And, of course, this is the kernel of many disputes, including 
those in Scardoni and Grover above, and Jin and Golubchuk below. 
A similar approach prevails in Canada, as is obvious from both E. (Mrs.) v. Eve,47 and 
Norberg v. Wynrib,48 which equally make clear that determining the ‘best interests’ of 
another requires information, deliberation and integrity.  It is complicated where, as is often 
the case, one of the relevant parties has personal interests that might bias the assessment.  Of 
the three legislative schemes, only the Ontario Act facilitates the ‘best interests’ assessment 
through the enumeration of relevant criteria:49 
 
• the patient’s known values and beliefs; 
                                                 
42  [1990] 3 All E.R. 930 (C.A.). 
43  Ibid, at 938. 
44  See also Airedale NHS Trust v. Bland, [1993] 1 All E.R. 821 (H.L.), wherein the Lords agreed that best 
interests must be given a generous interpretation that encompasses medical, emotional and other welfare issues, 
and which emphasises the sanctity of life.  In the mental health setting, best interests has been held to include 
social considerations: see R. v. Bournewood Mental Health Trust ex parte L, [1999] A.C. 458 (H.L.). 
45  [2005] 1 F.L.R. 491 (H.C. Fam.) 
46  This latter claim is equally applicable in Canada: see CMA, “Joint Statement on Resuscitative 
Interventions” (1995) 153 C.M.A.J. 1652A-C, Senate Committee on Euthanasia & Assisted Suicide, Of Life and 
Death (Ottawa: Supply & Service Canada, 1995), and Child & Family Services of Central Manitoba v. Lavallee 
et al. (1997), 154 D.L.R. (4th) 409 (Man. C.A.). 
47  [1986] 2 S.C.R. 388. 
48  [1992] 2 S.C.R. 226. 
49  See s. 21(2), HCCA (Ont). See also s. 66, SDA (Ont).  Under s. 4, MCA (UK), the patient’s best 
interests are determined by considering “all the relevant circumstances”, including whether the patient is likely 
regain capacity with respect to the matter in question and when that might be; (b) the patient’s beliefs and values 
that would likely influence a capacity-supported decision by the patient; (c) the patient’s past and present wishes 
and feelings; (d) other factors that the patient would likely consider; (e) the opinions of anyone named by the 
patient as someone to be consulted on the matter in question; (f) the opinions of those with responsibility for the 
patient’s welfare (e.g.: care-givers); (g) the opinions of donees of “lasting power of attorney” or court-appointed 
deputies.  The SDM is not entitled to base the decision on the patient’s age, appearance, condition, or aspects of 
behaviour which might lead to unjustified assumptions about best interests, nor can s/he be motivated (where 
life-sustaining treatment is concerned) by a desire to bring about the patient’s death. 
 
• the patient’s express wishes for treatment (that are non-binding); 
 
• whether the treatment is likely to (1) improve the patient’s condition or wellbeing, (2) 
prevent the patient’s condition or wellbeing from deteriorating, or (3) reduce the 
extent or rate which the patient’s condition/wellbeing is likely to deteriorate; 
 
• whether the patient’s condition/wellbeing is likely to improve, hold, or deteriorate 
without treatment; 
 
• whether the expected benefit to the patient outweighs the risk of harm; and 
 
• whether a less restrictive/intrusive treatment would be as beneficial as that proposed. 
 
The Ontario Act also recognises the depth of the assessment these criteria impose, and 
therefore entitles the SDM to information such as the nature of the proposed and alternative 
treatments, the expected benefits and material risks (including side effects) of the proposed 
and alternative treatments, and the likely consequences of no treatment.50 
In Jin and Golubchuk, the remaining subject cases, neither patient had executed an 
AD and decision-making had devolved to the children and physicians upon incapacity.  These 
parties disagreed as to the appropriate course.  In short, like the previous cases, there was a 
dispute over what constituted the patients’ best interests, but, uniquely, the disputes stemmed 
from the imposition by the physicians of Do-Not-Resuscitate orders on the patients’ charts 
without consulting or getting consent from the families.  As both judgments are on the limited 
question of the propriety of granting or continuing an interim injunction, neither completely 
dispose of the question. 
In Jin, the patient’s daughter sought an emergency interim injunction enjoining the 
hospital from exercising a DNR order that was imposed simply by virtue of her father’s 
classification as a Level-2 patient pending the decision of the hospital ethics committee.  The 
DNR order had been issued by the ICU physicians as a result of their opinion, after six CAT 
scans and a worsening of Jin’s condition, that Jin had entered a persistent vegetative state and 
would likely succumb to his head injury.  The daughter believed Jin’s condition was not so 
hopeless, and further argued that her brother should be permitted to travel to Canada before 
Jin died.  On the basis of the narrow scope of the application, the Court had to determine (1) 
whether a serious issue existed, (2) whether there would be irreparable harm absent an order, 
and (3) whether the balance of convenience favoured the granting of the remedy. 
On the first question, it articulated the issue as: who decides about a DNR order when 
the patient cannot, and the family and physicians disagree?  It noted an absence of Alberta 
authority and the possible constitutional implications, and concluded that there existed a 
complex legal issue demanding a full hearing involving all relevant parties canvassing all 
relevant considerations.  On the second question, it accepted that there was a clear possibility 
of irreparable harm to Jin if the DNR order was not lifted; while he may not require or 
survive resuscitation, damages would be inadequate if he were permitted to die.  On the 
                                                 
50  See s. 22(1), HCCA (Ont).  Although the English Act does not articulate specific medical information 
to which the SDM is entitled (from physicians or others), the direction that s/he consider “other factors that the 
patient would likely consider” implies the facilitation of requests from an SDM for information regarding 
treatment benefits, burdens, intrusiveness, risks and alternatives including non-treatment.  This position is 
bolstered by s. 36(2), MCA (UK), which entitles the authority to make regulations relating to mental capacity 
advocates which include requiring the advocate to obtain relevant information, ascertain alternative courses of 
action for the patient and further medical opinions. 
balance of convenience question, the Court held that granting the injunction was supported: 
 
[40] ...  While an injunction is an extraordinary remedy, this is an 
extraordinary situation.  I take into account the crucial nature of this decision; 
the importance of informed decision-making; the family’s stated need for 
more time to understand and assess the medical information ... ; the real risk 
of cardiac arrest at any moment ... ; that Mr. Jin [had been] healthy ... ; and 
the fall occurred just over a week ago.  The impact of the son wanting to 
attend upon his father is a less weighty consideration.  ...  On the other hand, 
the medical practitioners are said to agree that a DNR order is warranted; an 
injunction may require physicians to practice in ways they believe are not in 
their patient’s best interests; and even though it was not argued by anyone I 
have taken into account that medical services are resources to be allocated.  I 
am mindful that the injunction is for a brief period and on balance I prefer to 
rescind the DNR order, and preserve the status quo until there is either 
consensus or a legal determination on full evidence. 
 
In the result, a 24-hour injunction was granted, using the wording and classifications utilised 
by the hospital so as to be readily comprehensible to front-line workers, and it was 
accompanied by an order that the hospital share information with the family.51 
In Golubchuk, after fashioning a treatment plan with the hospital ethics committee, 
the treating physician informed the family that he intended to remove Golubchuk (G) from 
life support.  The family, acting through G’s son, obtained an emergency interim injunction 
restraining him.  The defendant’s evidence was that G had a complete loss of consciousness, 
rarely opened his eyes, was unresponsive to stimuli, and unable to follow simple commands.  
The family produced an affidavit of a neurologist who, upon reviewing the hospital record, 
noted the absence of neurology examinations, CAT scans or MRIs, and of assessments for 
treatable neurological illnesses which might account for his apparent lack of consciousness.  
The evidence also indicated that discontinuing life support would involve some interaction 
with G’s body (ie: the necessary provision of narcotics) and would lead to his passing sooner 
than if he remained on the ventilator. 
The Court opined that in cases of non-consensual medical decisions, be they to 
provide, withdraw, or refuse treatment, there is a role for the courts in making factual 
determinations and advising of the legality of disputed decisions.  Given the issue – whether 
an injunction should be continued until trial – it articulated its role as deciding whether it was 
‘just or convenient’ to do so.  First, however, it reviewed two judgments concerning 
withdrawal of treatment absent consent.  The first, Manitoba (Child & Family Services) v. 
R.L.,52 saw an infant admitted to hospital in a vegetative state from which there was no hope 
of recovery.  Physicians recommended a DNR order, but his parents, suspects in the 
precipitating attack, opposed the order.  The Court noted that the placement of a DNR order 
involves no commission equivalent to an assault and so no consent or court order in lieu 
thereof is required.  The second, Sawatzky v. Riverview Health Centre Inc.,53 saw a 79 year-
old Parkinson’s sufferer with chronic aspiration pneumonia and dementia deteriorate such 
that physicians placed a DNR order on his chart without consulting his wife, who sought an 
injunction.  The Court noted that R.L. suggested that decisions not to provide treatment are 
within the purview of the physician, but that case failed to consider the effect of the Charter 
                                                 
51  It is worth noting that relations between the physicians, hospital, and family remained cooperative 
throughout, in stark contrast to how completely relations broke down in Scardoni. 
52  (1997), 154 D.L.R. (4th) 409 (Man. C.A.). 
53  (1998), 167 D.L.R. (4th) 359 (Man. Q.B.). 
and Human Rights Code.  It therefore granted the injunction. 
According to the Court, the strength of the patient’s case turned on who properly has 
final say in the event of impasse and that often turns on whether the intervention requires a 
commission or omission.  On that point, it held: 
 
[25] [It] is not settled law that, in the event of disagreement between a 
physician and his patient as to withdrawal of life supports, the physician has 
the final say.  In Sawatzky, the court held that there was an untested triable 
issue relating to the applicability of the Charter ... [and even] if the Charter 
does not apply, common law principles must develop in keeping with Charter 
values, which include respect for religious freedom and respect for life and 
personal autonomy ... .  ... The decision in R.L. ... does not resolve the issue of 
who has the right to decide whether to withdraw a ventilator that has been put 
in place.  Should this issue be resolved by whether the treatment in question is 
an act of commission or omission?  Should withholding of treatment and 
withdrawal of treatment be treated the same?  Are there other criteria or factors 
to be considered?  Does the plaintiff have a right to continuation of the 
treatment that is in place, either at common law or under the Charter?  In my 
view, the resolution of these questions is wide open ... [and] are not frivolous. 
 
Given these conclusions, the Court decided the remaining factors as follows: 
 
• Sufficiency of Damages:  Damages would not be adequate for G because if he died 
after disconnection, no judicial relief could compensate him or his family. 
 
• Balance of Convenience:  Continuation of the injunction could mean compelling the 
physicians to treat despite ethical concerns.  It could also mean, G may be afforded an 
opportunity to be heard fully on his positions.  Balance favours G. 
 
• Desirability of Status Quo:  G is on a ventilator because the physicians placed him 
there; we might assume that, at one point, doing so squared with an ethical 
assessment.  Status quo favours G. 
 
• Special Circumstances:  A question exists pertaining to the right that should be 
afforded to patients to be provided with a written outline of the procedures available 
and an opportunity to have any disagreement addressed with the help of 
knowledgeable, trained, objective mediators from outside the hospital (as 
recommended by the Law Reform Commission). 
 
In the result, it concluded that it was ‘just and convenient’ to make an order continuing the 
injunction until a trial decision issued. 
As these cases addressed the very short-term best interests of the patients rather than 
their ultimate best interests, they neglected to engage with the full best interests criteria 
enumerated above.  One hopes that when the parties’ rights are finally settled, the courts will 
indeed explore in detail this criteria and the underlying values.  Additionally, important 
questions raised by these cases include: 
 
• Might permitting physicians to act independently (and have final say) mean a return 
of paternalism? 
 
• Might such an approach result in an erosion of patient autonomy, and of trust? 
 
• Might the determination of this question finally offer a frank and explicit judicial 
discussion of how resource allocation (should) play into these decisions? 
 
• How might the competing interests and values be balanced, and how might patient 
rights be weighed against physician rights (as shaped by their interpretation of their 
ethical duties)? 
 
That the implications of non-consultation based on opinions of futility could be far reaching 
is thus obvious.54   
In neither case did the court give an indication of where it stood with relation to un-
consulted impositions of DNRs, nor were any core values explicitly explored, though a clear 
affinity with the sanctity of life was evinced, the courts being concerned to preserve life – 
even life of questionable value from an experiential perspective – at least until final 
determination of the issue.  Indeed, this sanctity of life value is implicated by the best 
interests approach more generally.  This value gives recognition to the special gift that is life.  
In its strictest formulation (commonly referred to as ‘vitalism’), life is inviolable, and 
demands preservation at all costs.  A milder formulation suggests that human life be treated 
with reverence and respect, but its preservation is linked to considerations of other life-
dependent interests, needs, desires, attributes and qualities (ie: that complex of powers and 
interests that we collectively call the person).55  This non-absolute formulation, assumes an 
aversion to harm, which implicates principles such as non-maleficence and beneficence.  
While Scardoni and Grover seemed to adopt the milder formulation, the Jin and Golubchuk 
courts seemed to adopt the stricter formulation for the purpose of these applications; 
suggesting a judicial awareness of the differing needs in different circumstances, even from a 
value perspective. 
The best interests approach, together with (all of) the cases also serve as a means of 
realising a justice value; extending fairness to those in the process of dying (and to their 
SDMs).  The particular manifestation of justice implicated here is administrative; the 
assurance of representation (and choice in same), and of access to a framework for conflict 
resolution.  From a value perspective, it encompasses fair, equitable and appropriate 
treatment in light of what is owed to the individual by his/her community, including an 
appropriate opportunity to share in available resources, through the provision of care based 
on medical expertise, medical need, and individual interests.  The shift from patient wishes to 
more objective approach limits the third party SDM’s opportunity to relegate the patient’s 
interests to a position of subservience to their own; it protects the patient from harm but it 
also permits experts to play a greater role as one’s own faculties dim.  Ultimately, then, 
although Jin and Golubchuk are only prologues to the resolution of a very important question, 
they do disclose the translation of end-of-life values into practice, and rather consistently so. 
 
 
                                                 
54  In R. (on the application of Burke), supra, note 19, the Court accepted evidence that 50,000 patients are 
admitted to ICUs annually in the UK, 30% of whom die before discharge, most because treatment is withdrawn 
or limited (ie: clinicians conclude that such treatment would likely only prolong the process of dying).  
Importantly, this is done even when there is disagreement on the part of those concerned.  The Court held that it 
is incumbent on physicians to seek legal advice, but not necessarily court approval of their conduct.  It 
concluded that good practice may demand that physicians seek such a declaration where the legality of proposed 
treatment is in doubt, but they are not required to do so as a matter of law. 
55  P. Suber, supra, note 41, at 6-7. 
 
 
CONCLUSION & RECOMMENDATIONS FOR END-OF-LIFE PRACTICE 
 
The scope of this paper has been fairly wide ranging: it addressed the treatment of consent, 
capacity, best interests, and the role of ADs in Canada, both legislatively and judicially.  
Conversely, the ambition has been reasonably limited: to elucidate recent judicial holdings on 
practices around these important end-of-life concepts, and to identify some core values 
implicated, thereby touching upon the underexplored area of the interaction between socio-
ethical values and law, and the translation of values into statutory rules and judicial 
declarations.  The above un-philosophical approach was intended to merely highlight the fact 
that ethical values are deeply entrenched in this area of the law, and are becoming ever more 
explicitly referenced as authority for making particular decisions.56  The most important 
values appear to be dignity, autonomy, sanctity of life, justice, and trust, all of which have a 
role in informing practices around consent, capacity to consent, and the determination of best 
interests in end-of-life situations. 
As indicated in the Introduction, the foregoing was also intended to underpin some 
recommendations for medical/family lawyers practising in this area.  Given the increasing 
likelihood of clients facing such ends, given our desire to avoid Schiavo-type situations, and 
given the prevailing legal environment (which creates a powerfully useful space for ADs but 
contains patches of imprecision), it is appropriate to consider the lawyer’s function, which 
must start from a recognition that s/he has an ethical duty to be competent, and to serve the 
client in a conscientious, diligent and efficient manner.57  As a starting point, lawyers must 
accept that ethical values (and ethics) are more than minimally useful abstractions; though 
they can be vague, reflection on them (even well short of deep philosophical introspection) 
and an appreciation of their relationship to medical decision-making, will empower lawyers 
to better counsel clients in end-of-life situations, thereby enriching client decision-making. 
As a start, lawyers must understand that most patient’s (and their SDMs) want a ‘good 
death’.  Although this will vary from client to client, a recent study indicates that important 
elements of this include: (1) trust and confidence in the treating physician; (2) avoidance of 
unwanted life support when there is little hope for meaningful recovery; (3) honest 
communication of medical information; (4) preparation for life’s end (life review, conflict 
resolution, goodbyes); and (5) avoidance of becoming a physical or emotional burden on 
family.58  Unfortunately, studies have also found that end-of-life processes are poorly 
managed, often due to insufficient information provided to SDMs.59  This is a lacunae 
                                                 
56  Thus, the age-old ‘dodge’ that courts have used (ie: the claim that they are arbiters of law, not ethics: 
see Rodriguez, supra, note 1, and R. (on the application of Pretty) v. D.P.P., [2002] 1 A.C. 800 (H.L.), wherein 
Lord Hope, at para. 85, stated that it was not for the court to form a judgment on the ethical or moral issues 
raised, but rather to answer the questions of law asked) is less compelling in the medical context.  More recent 
cases, including R. (on the application of Burke), supra, note 18, suggest a greater willingness to engage with 
value-based and ethical terminology, and a growing direct judicial commitment to them. 
57  Chapter II, Competence and Quality of Service, CBA Code of Professional Conduct (Ottawa: CBA, 
1987). 
58  D. Heyland et al., “Decision-Making in the ICU: Perspectives of the Substitute Decision-Maker” 
(2002), at www.springerlink.com [accessed 17 March 2006].  A similar ranking of elements was obtained from 
patient family members. 
59  See S. Mitchell & F. Lawson, “Decision-Making for Long-Term Tube-Feeding in Cognitively 
Impaired Elderly People” (1999) 160 C.M.A.J. 1705-1709, who also cites R. Schonwetter et al., “Tube-Feeding 
Decisions in Nursing Home Patients: Informed or Not?” (1996) 44 J. Am. Ger. Soc. S51 
lawyers must endeavour to rectify, for the consequences to those navigating these difficult 
waters are (1) indecision, (2) inappropriate deference to others, and (3) intractable disputes.60 
As trusted participants in end-of-life processes, lawyers must (do more to) prepare 
clients, and that means addressing the legal and ethical responsibilities of all parties, as well 
as the limits of their powers.  An important mechanism for doing this, and for ensuring that 
disputes are minimised, is to employ ADs.61  Bearing all of the above in mind, lawyers might 
adopt the following practices in preparing clients (and SDMs) for the potential ordeal ahead: 
 
• The lawyer should encourage the client/patient to choose someone s/he is close to and 
trusts, using the same criteria for appointing a named second.  Given that the majority 
of SDMs prefer to share decisional responsibility with physicians, or defer 
responsibility to physicians altogether,62 the lawyer should advise the client/patient to 
explore with the SDM the role s/he (the SDM) wishes to adopt (ie: active or passive 
with respect to decisional burden).  Regardless of the decisional approach adopted, the 
SDM should be strongly encouraged to take an active approach insofar as maintaining 
regular contact with the client/patient and other supportive family and friends before 
incapacity, and to continue to consult with that support network after incapacity is 
established. 
 
• The lawyer should strongly advise (or ensure) that the SDM has adequate direction 
from the client/patient, thereby enhancing the SDM’s authority if a dispute arises 
between the SDM and the client/patient’s treatment team.  This may mean facilitating 
a frank and open discussion between the client/patient and the SDM in the office.  
Such a discussion should explore: (1) the values of each party (including those ethical 
values identified above); (2) ideas around quality of life and functional tolerances; (3) 
possible (and most feared) health scenarios; (4) the parties’ understanding of the 
treatment decisions which may be confronted; (5) areas needing medical clarification; 
and (6) most relevant statutory tests such as best interest factors. 
 
• Given the likelihood of tube-feeding (or artificial nutrition and hydration) should the 
client/patient endure to old age,63 the lawyer should foster a discussion (between 
client/patient and SDM) on this specific issue, particularly in light of (1) the evidence 
suggesting its minimal effectiveness as a ‘treatment’ for preventing aspiration or 
prolonging life, (2) the relative burden it represents to patients, and (3) the 
considerable expense it represents to the healthcare system (which may be a 
considerable factor in the medical facility’s determination that it is either not 
medically indicated, or a prudent use of limited resources given competing needs).64 
                                                 
60  On this latter point, it was lamented in Wyatt v. Portsmouth NHS Trust, [2005] E.W.C.A. Civ. 1181 
(C.A.), that it is “a matter of regret” when the debate relating to the treatment of a seriously disabled person 
needs to be conducted in a courtroom.  It is even more regrettable when the dispute dissolves into the mistrust 
and acrimony characterized by Schiavo (although the chances of a Schiavo-type frenzy occurring is reduced by 
the very different legal-political culture in Canada and the UK). 
61  Although we can see from the cases above, particularly Grover, that even having an AD does not 
eliminate the possibility of disputes necessitating judicial determination. 
62  D. Heyland et al., supra, note 58. 
63  According to D. Heyland et al., “What Matters Most in End-of-Life Care: Perceptions of Seriously Ill 
Patients and Their Family Members” (2006) 174 C.M.A.J. Online, over 70% of Canadians die in hospital as 
elderly patients. According to S. Mitchell & F. Lawson, supra, note 59, 10% of elderly people in chronic care 
facilities are tube-fed. 
64  See S. Mitchell & F. Lawson, ibid, and the 12 studies cited therein.  See S. Mitchell et al., “A Decision 
Aid for Long-Term Tube Feeding in Cognitively Impaired Older Persons” (2001) 49 J.A.G.S. 313-316. 
 
• When drafting an AD, the lawyer should articulate the client/patient’s general values 
and outlook on life and death, as well as specific as possible, articulating scenario-
specific guidance for SDMs. 
 
By doing this, lawyers improve their chances of promoting legally effective and ethically 
sound conduct which conforms to patient wishes in an otherwise highly emotive situation; 
they improve their chances of being responsible officers of the court, effective counsellors, 
and valuable participants). 
